Skip to main content
. 2023 Nov 2;23:443. doi: 10.1186/s12886-023-03174-y

Fig. 7.

Fig. 7

Proportion of patients remaining on index treatment after the index date. P-value for analysis of OTX-101 vs. CsA. The Day 360 P-value is statistically significant as based on a significance level of < 0.05. P-value for analysis of OTX-101 vs. LFT. CsA, cyclosporine ophthalmic emulsion 0.05%; LFT, lifitegrast ophthalmic solution 5%; OTX-101, cyclosporine ophthalmic solution 0.09%